×

Stocks Merck & Co Inc

  • The Baltic Dry Shipping Index, a leading economic indicator used by market insiders to gauge global demand for dry commodities, hit another year-high on Wednesday. Urs Dur, vice president and logistics analyst at Lazard Capital Markets, discussed the index's significance and what investors should expect going forward.

  • Trading desks idle as light volume continues. It started on November 1st — sell-side desks started seeing a drop in trading volume, and it has continued through the month. What gives?

  • As the year draws closer to an end, investors are looking ahead to new investment strategies for 2010. Tobias Levkovich, chief U.S. equity strategist at Citigroup, shared his outlook.

  • When I do an interview with a clinical trial investigator I typically try to take care of what I call the "housekeeping" at the beginning or end.

  • Stocks opened lower on Tuesday, after a sharp rally in the prior session. Where should investors be looking and how should they play the markets? David Spika, VP and investment strategist at WHG Funds and Bill Smead, CEO and CIO of Smead Capital Management shared their outlooks.

  • A smart speech by the Fed chief has given investors the green light.

  • Live TV is best when things are happening and news is breaking right now. It's immediate and often, hopefully, more compelling.

  • Winterizing Your Portfolio - A CNBC Special Report

    The Dow pared its gains in the final hour of trading after banking analyst Meredith Whitney said the recent market rally is not rooted in fundamentals and the U.S. economy is likely to fall back into a recession next year.

  • Plus, get calls on tech, pharma and more.

  • Winterizing Your Portfolio - A CNBC Special Report

    Stocks opened higher Monday, building on two weeks of gains, as a weak dollar boosted commodity stocks and a government report showed retail sales rose in October.

  • Winterizing Your Portfolio - A CNBC Special Report

    Stocks opened higher Monday, building on two weeks of gains, as a weak dollar boosted commodity stocks and a government report showed retail sales rose in October.

  • pills_prescription_200.jpg

    Even as drug makers promise to support Washington’s health care overhaul by shaving $8 billion a year off the nation’s drug costs after the legislation takes effect, the industry has been raising its prices at the fastest rate in years, reports the New York Times.

  • Winterizing Your Portfolio - A CNBC Special Report

    Stock index futures are pointing to a higher open Monday after data showed that Japan's economy grew nearly twice as much as expected in the third quarter.

  • Winterizing Your Portfolio - A CNBC Special Report

    Stocks clawed higher Friday as solid earnings from Disney and JCPenney helped offset worries about a drop in consumer sentiment. It was a wobbly morning but by midday, the  Dow was up more than 100 points, or 1 percent.

  • Merck

    For top analysts from investment banks, including JPMorgan  and Credit Suisse , or some of their minions, the destination is a cardiology conference where on Monday morning medical researchers are expected to present a study with potentially significant implications for multibillion-dollar cholesterol medications from the drug giant Merck.

  • It doesn't always happen, but there is a common to-and-fro, push-and-pull, back-and-forth or whatever you want to call it between reporters and corporate PR folks. I don't particularly like that part of my job, but sometimes it just comes with the territory. I've got my job to do and they've got theirs. I get it.

  • Winterizing Your Portfolio - A CNBC Special Report

    Stocks wobbled Friday as investors juggled a drop in consumer confidence against solid earnings from Disney and JCPenney. They started the day higher, then retreated, then made another push higher.

  • Health Care Reform

    Many analysts, lobbyists and industry executives have been saying for months that healthcare reform would probably end up being a net positive for the drug companies.

  • These firms would make great acquisitions for big drug companies looking to expand their cancer portfolios.

  • Winterizing Your Portfolio - A CNBC Special Report

    Stocks ended mixed Wednesday as a post-Fed rally fizzled. Stocks had opened higher as investors cheered some encouraging readings on the economy, then swung in about a 50 point range after the Fed's statement, before finishing narrowly mixed.